Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI
· Real-Time Price · USD
14.15
0.19 (1.36%)
At close: May 15, 2025, 3:59 PM
14.16
0.04%
After-hours: May 15, 2025, 04:14 PM EDT
Denali Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|
| Alzheimer's Disease Services Revenue | 3.4M | 3.5M | 3.9M |
| Alzheimer's Disease Services Revenue Growth | -2.86% | -10.26% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 29.35M | 30.06M | 24.95M | 23.25M | 23.07M | 22.59M | 25.32M | 26.12M | 27.14M | 23.52M | 23.26M | 21.16M | 22.54M | 21.76M | 19.32M | 19.05M | 18.94M | 17.99M | 15.8M | 13.97M | 12.55M | 10.88M | 11.21M | 15.08M | 9.31M | 11.04M | 8.84M | 6.9M | 5.57M | 5.07M | 3.77M | 3.56M | 3.27M | 3.05M | 3.11M | 2.79M | 2.79M |
| Selling, General, and Administrative Revenue Growth | -2.35% | +20.48% | +7.30% | +0.77% | +2.13% | -10.79% | -3.04% | -3.76% | +15.41% | +1.10% | +9.92% | -6.13% | +3.59% | +12.63% | +1.44% | +0.58% | +5.24% | +13.85% | +13.12% | +11.29% | +15.41% | -3.00% | -25.61% | +61.93% | -15.71% | +24.97% | +28.16% | +23.81% | +9.88% | +34.35% | +5.86% | +8.86% | +7.49% | -2.15% | +11.74% | 0.00% | n/a |
| Research and Development Revenue | 116.23M | 99.79M | 98.24M | 91.4M | 107.02M | 107.8M | 89.74M | 97.52M | 128.82M | 92.11M | 87.79M | 92.74M | 86.1M | 67.88M | 71.56M | 65.71M | 60.21M | 54.74M | 53.7M | 53.15M | 51.02M | 51.55M | 52.54M | 51.88M | 37.4M | 39.91M | 30.32M | 52.13M | 20.82M | 18.47M | 18.52M | 19M | 18.47M | 16.73M | 27.82M | 15.58M | 15.58M |
| Research and Development Revenue Growth | +16.48% | +1.58% | +7.48% | -14.59% | -0.73% | +20.13% | -7.98% | -24.30% | +39.85% | +4.93% | -5.34% | +7.71% | +26.85% | -5.15% | +8.90% | +9.14% | +9.98% | +1.93% | +1.04% | +4.19% | -1.04% | -1.89% | +1.27% | +38.72% | -6.28% | +31.62% | -41.84% | +150.42% | +12.71% | -0.24% | -2.57% | +2.89% | +10.40% | -39.86% | +78.60% | 0.00% | n/a |